The GLP-1 Receptor Agonist Liraglutide Improves Hepatic Inflammation and Fibrosis in a Mouse Model of NASH

被引：3
|
作者：
Montandon, Sophie A.
Somm, Emmanuel
De Vito, Claudio
Jornayvaz, Francois R.
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1887-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1887-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] GLP-1 receptor agonist liraglutide has a neuroprotective effect on an aged rat model of Wolfram syndrome
    Seppa, Kadri
    Toots, Maarja
    Reimets, Riin
    Jagomae, Toomas
    Koppel, Tuuliki
    Pallase, Maia
    Hasselholt, Stine
    Mikkelsen, Maiken Krogsbaek
    Nyengaard, Jens Randel
    Vasar, Eero
    Terasmaa, Anton
    Plaas, Mario
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [22] Effect of the GLP-1 Receptor Agonist, Liraglutide as an Adjunct to Insulin Treatment in a Rodent Model of Type 1 Diabetes
    Meek, Thomas H.
    Kumar, Monica
    Matsen, Miles E.
    Fischer, Jonathan D.
    Taborsky, Gerald J., Jr.
    Schwartz, Michael W.
    Morton, Gregory J.
    DIABETES, 2013, 62 : A733 - A733
  • [23] Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
    Thiago Carvalho
    Nature Medicine, 2023, 29 : 1881 - 1881
  • [24] Efruxifermin combined with a GLP-1 receptor agonist reduces liver fat in NASH
    Carvalho, Thiago
    NATURE MEDICINE, 2023, 29 (08) : 1881 - 1881
  • [25] A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
    Gaspari, Tracey
    Liu, HongBin
    Welungoda, Iresha
    Hu, Yunshan
    Widdop, Robert E.
    Knudsen, Lotte B.
    Simpson, Richard W.
    Dear, Anthony E.
    DIABETES & VASCULAR DISEASE RESEARCH, 2011, 8 (02): : 117 - 124
  • [26] Delayed administration of the GLP-1 receptor agonist liraglutide improves metabolic and functional recovery after cerebral ischemia in rats
    Dong, Wenbin
    Miao, Yunping
    Chen, Aiying
    Cheng, Min
    Ye, Xiaodi
    Song, Fahuan
    Zheng, Gaoli
    NEUROSCIENCE LETTERS, 2017, 641 : 1 - 7
  • [27] The GLP-1 Receptor Agonist Liraglutide Attenuates Atherosclerotic Lesion Development and Potentially Enhances Plaque Stability in an ApoE-/- Mouse Model
    Simpson, Richard W.
    Gaspari, Tracey
    Welungoda, Iresha
    Widdop, Robert E.
    Knudsen, Lotte B.
    Dear, Anthony E.
    DIABETES, 2012, 61 : A486 - A486
  • [28] GLP-1 receptor agonist liraglutide inhibits the proliferation and migration of thyroid cancer cells
    Zhang, Xuelian
    Zhang, Liqiang
    Wang, Bo
    Zhang, Xuane
    Gu, Lei
    Guo, Kai
    Zhang, Xiaoyan
    Zhou, Zunhai
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (14) : 221 - 225
  • [29] Prevalence and variations in gastric emptying delay in response to GLP-1 receptor agonist liraglutide
    Camilleri, Michael
    Carlson, Paula
    Dilmaghani, Saam
    OBESITY, 2024, 32 (02) : 232 - 233
  • [30] DIFFERENT CGM EFECTTS OF GLP-1 RECEPTOR AGONIST: LIRAGLUTIDE VS. LIXISENATIDE
    Jesus, M. F.
    Garcia Seco, J. A.
    Rozas, P.
    Garcia Seco, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A98 - A98
12345